Skip to content

Dr. Goreti Ribeiro Morais

Information about Dr. Goreti Ribeiro Morais at the University of Bradford.

Some details are missing for this profile, including contact information. If this is your profile, please review guidance on how to report this issue.

Photo of Dr. Goreti Ribeiro Morais

Biography

Goreti Ribeiro Morais obtained her degree in Pharmacy from the University of Coimbra and received her PhD in Pharmaceutical Chemistry from the University of Lisbon (Portugal)/University of Kyushu (Japan). Then she conducted a three-year postdoctoral stay at the Institute of Cancer Therapeutics (ICT), University of Bradford followed by a research scientist position at the Radiopharmaceutical Sciences Group/Technical University of Lisbon. In late 2014 she moved back at the ICT as senior PDRA to integrate the Yorkshire Cancer Research Programme grant. She made significant contributions towards three main medicinal chemistry projects (polysialyltransferase inhibitors, Cytochromes P450-activated prodrugs, and MMP-activated prodrugs) of the ICT and was crucial for the strengthening of the collaborations with Stanford University, Incanthera and Ellipses Pharma. Since 2019 she has played a key role in the successful Incanthera-funded doctoral Training centre (DTC-ICT). In addition to the training and mentoring of the medicinal chemistry postgraduate students of the ICT, she acted as formal co-supervisor of three PhD students (each successfully completed, and have secured excellent jobs in industry (2) and academia (1)) and two international undergraduate students. Currently she is co-supervisor of one PhD student and one MSc student. She has authored 50 peer-reviewed journal articles, 7 of which as corresponding author, 1 book chapter, 1 patent and 17 published abstracts in international conferences. Moreover, she has teaching responsibilities in three Master courses and holds a PAT role for MPharm students.

Professional activities

Information about education, employment and areas of particular interest for Dr. Goreti Ribeiro Morais is as follows:

Employment

  • University of Bradford - Senior Post-Doctoral Fellow in the year 2014 (specified as 06/10/2014)

Education

  • University of Coimbra, Portugal - PGDipPharm
  • University of Lisbon, Portugal - PhD Thesis

Publications

There are 40 publications involving or that are attributed to Dr. Goreti Ribeiro Morais. They are listed as:

  • chapter in book (1)
  • peer reviewed journal (39)

Chapter in Book

Dr. Goreti Ribeiro Morais has 1 publication(s) listed under chapter in book.
Title Year Publication name Journal Volume Pages Authors Editors ISSN Publisher DOI Location
Organometallic Chemistry of Rhenium and Technetium Fueled by Biomedical Applications 2013 ISBN: 9781118510148 10.1002/9781118742952.ch44

Peer Reviewed Journal

Dr. Goreti Ribeiro Morais has 39 publication(s) listed under peer reviewed journal.
Title Year Publication name Journal Volume Pages Authors Editors ISSN Publisher DOI Location
Biophysical Characterization and Antineoplastic Activity of New Bis(thiosemicarbazonato) Cu(II) Complexes 2017 Journal of Inorganic Biochemistry 10.1016/j.jinorgbio.2016.11.026
Acid catalysed reaction of indanones, tetralones and benzosuberone with neopentyl glycol and other alkanediols under forced conditions 2010 Journal of Chemical Research-S 10.3184/030823410X12753214605445
Acid catalysed reaction of estrones with neopentyl glycol under forced conditions 2010 Journal of Chemical Research-S 10.3184/030823410X12678785299942
Steroid receptor ligands for breast cancer targeting: an insight into their potential role as PET imaging agents 2013 Current Medicinal Chemistry 10.2174/092986713804806658
Application of HOF·CH3CN to the synthesis of glycosyl sulphones 2008 Tetrahedron 10.1016/j.tet.2008.05.033
Novel strategies for the synthesis of unsymmetrical glycosyl disulfides 2016 Organic and Biomolecular Chemistry doi.org/10.1039/C6OB00230G
Efficient one-pot synthesis of glycosyl disulphides 2007 Tetrahedron Letters 10.1016/j.tetlet.2007.08.106
Radioiodinated ligands for the estrogen receptor: effect of different 7-cyanoalkyl chains on the binding affinity of novel iodovinyl-6-dehydroestradiols 2009 Applied Radiation and Isotopes 10.1016/j.apradiso.2008.10.005
Selective synthesis of Neu5Ac2en and its oxazoline derivative using BF3.Et2O 2009 Tetrahedron Letters 10.1016/j.tetlet.2009.01.117
A synthetic overview of radiolabeled compounds for β-amyloid targeting 2012 European Journal of Organic Chemistry 10.1002/ejoc.201101449
Organometallic complexes for SPECT Imaging and/or Radionuclide Therapy 2012 Organometallics 10.1021/om300501d
Carbohydrate-based molecules suitable for nuclear molecular imaging 2013 European Journal of Organic Chemistry 10.1002/ejoc.201201457
Progesterona receptor targeting with radiolabelled steroids: an approach in predicting Breast Cancer Response to Therapy 2013 Journal of Steroid Biochemistry and Molecular Biology 10.1016/j.jsbmb.2013.04.003
Radiosynthesis and in vivo Evaluation of a 18F-Labelled Styryl-Benzoxazole Derivative for beta-Amyloid Targeting 2013 Applied Radiation and Isotopes 10.1016/j.apradiso.2013.07.003
The Tumor-Targeted Prodrug ICT2588 Demonstrates Therapeutic Activity Against Solid Tumors and Reduced Potential For Cardiovascular Toxicity 2014 Molecular Pharmaceutics 10.1021/mp400760b
Isostructural Re(I)/99mTc(I) Tricarbonyl Complexes Functionalized with Benzothiazole Derivatives for Cancer Theranostic 2015 Organic and Biomolecular Chemistry 10.1039/c5ob00124b
Polysialic acid sustains cancer cell survival and migratory capacity in a hypoxic environment 2016 Scientific Reports 10.1038/srep33026
Synthesis and Biological Evaluation of Novel 2-Aryl Benzimidazoles as Chemotherapeutics Agents” 2017 Journal of Heterocyclic Chemistry 10.1002/jhet.2575
Unravelling the antitumoral potential of novel bis(thiosemicarbazonato) Zn(II) complexes: structural and cellular studies 2019 Journal of Biological Inorganic Chemistry 10.1007/s00775-018-1629-6
An efficient assay for identification and quantitative evaluation of potential polysialyltransferase inhibitors 2020 The Analyst doi.org/10.1039/D0AN00721H
How can the potential of the duocarmycins be unlocked for cancer therapy? 2021 Drug Discovery Today 10.1016/j.drudis.2020.11.020
Probing cytochrome P450 (CYP) bioactivation with chloromethylindoline bioprecursors derived from the duocarmycin family of compounds 2021 Bioorganic and Medicinal Chemistry 10.1016/j.bmc.2021.116167
Cytochrome P450 isoforms 1A1, 1B1 AND 2W1 as targets for therapeutic intervention in head and neck cancer 2021 Scientific Reports 10.1038/s41598-021-98217-z
Targeted delivery of a colchicine analogue provides synergy with ATR inhibition in cancer cells 2022 Biochemical Pharmacology 10.1016/j.bcp.2022.115095
Dess–Martin periodinane-mediated oxidation of the primary alcohol of cytidine into a carboxylic acid 2024 Organic and Biomolecular Chemistry 22 Serre, A.R.E;Jha, V.;Rivault, A.;Eriksson, L.A.;Ribeiro Morais, G.;Falconer, R.A. Royal Society of Chemistry 10.1039/d4ob00240g
Simple amidation of non-protected phenol containing 2-alkenoic acids 2005 Journal of Chemical Research-S 10.3184/030823405775146889
Synthesis and in vitro evaluation of fluorinated styryl benzazoles as amyloid-probes 2011 Bioorganic and Medicinal Chemistry 10.1016/j.bmc.2011.09.065
An optimized method for the synthesis of amino functionalized phosphatidylcholine 2012 Tetrahedron Letters 10.1016/j.tetlet.2011.11.100
Probing cytochrome P450 bioactivation and fluorescent properties with morpholinyl-tethered anthraquinones 2018 Bioorganic and Medicinal Chemistry Letters 10.1016/j.bmcl.2018.03.040
Theranostic nanoparticles enhance the response of glioblastomas to radiation 2019 Nanotheranostics DOI: 10.7150/ntno.35342
Glycosyl disulfides: importance, synthesis and application to chemical and biological systems 2021 Organic and Biomolecular Chemistry doi.org/10.1039/D0OB02079F
Chemoselective Solution- and Solid-Phase Synthesis of Disulfide-Linked Glycopeptides 2022 Journal of Organic Chemistry doi.org/10.1021/acs.joc.2c01651
An assay for quantitative analysis of polysialic acid expression in cancer cells 2021 Carbohydrate Polymers 10.1016/j.carbpol.2021.117741
Pharmacological inhibition of polysialyltransferase ST8SiaII modulates tumour cell migration 2013 PLoS ONE 10.1371/journal.pone.0073366
A Novel Theranostic Strategy for MMP-14–Expressing Glioblastomas Impacts Survival 2017 Molecular Cancer Therapeutics 10.1158/1535-7163.MCT-17-0022
Azodicarboxylate-Mediated Peptide Cyclisation: Application to Disulfide Bond Formation in Solution and Solid Phase 2023 European Journal of Organic Chemistry doi.org/10.1002/ejoc.202300789
Identification of an acetyl disulfide derivative in the synthesis of thiosialosides 2010 Carbohydrate Research 10.1016/j.carres.2009.10.017
Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents 2022 Drug Metabolism and Disposition doi.org/10.1124/dmd.121.000642
A facile preparation of thio-trehalose analogues – 1,1-thiodissacharides 2009 Carbohydrate Research 10.1016/j.carres.2009.03.017